Liposomes: A Review

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-04-02-2002
Volume 26
Issue 4

In Part I of this two-part series, the authors discuss the need to follow GMPs for lipid-vesicle fabrication that result in size uniformity, delivery of sufficient drug concentration, and stability.

External Link - article-14095.pdf

Articles in this issue
Effect of Extragranular Microcrystalline Cellulose on Compaction, Surface Roughness, and In Vitro Dissolution of a Self-Nanoemulsified Solid Dosage Form of Ubiquinone
The Usefulness of 0.45 &#181m&#150Rated Filter Membranes
Outsourcing Outlook
Monitoring Blend Uniformity with Effusivity
Using Ion Mobility Spectrometry for Cleaning Verification in Pharmaceutical Manufacturing
Bush Budget Combats Bioterrorism, Promotes Drug Safety
Alteration in Dissolution Characteristics of Gelatin-Containing Formulations: A Review of the Problem, Test Methods, and Solutions
E-Procurement — Successfully Using and Managing Reverse Auctions
Liposomes: A Review
Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

New CDMO Meribel Pharma Solutions Launches with 13 Sites in Europe

Patrick Lavery
April 16th 2025
Article

The new United Kingdom-based firm has sites located in France, Spain, and Sweden, thanks to an acquisition of Synerlab Group and several Recipharm facilities in 2024.

Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Bayer Announces FDA’s First Full Approval of NTRK Inhibitor

Patrick Lavery
April 14th 2025
Article

Vitrakvi (larotrectinib) was first granted accelerated approval by FDA in November 2018.

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

BDD Opens GMP Manufacturing Facility in Scotland

Patrick Lavery
April 11th 2025
Article

Development of the state-of-the-art facility was made possible by a £2 million (US$2.6 million) round of funding, and a successful inspection by MHRA was completed in March 2025.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Novartis to Expand US-Based R&D and Manufacturing

Susan Haigney
April 11th 2025
Article

The company has plans to invest $23 billion during the next five years to expand manufacturing and R&D in the US, which will include seven new facilities.